Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors
Related Posts
Freeman M, Gates G, Ahronowitz I. Decade Growing in Plain Sight: Detection of an Invasive Melanoma Within a Long-Standing Pigmented Lesion. Cureus. 2026 Oct 10;18(10):e117734.[...]
Moon JY, Zhou AE, Soriano T, Davis J, Kim J, Grant-Kels JM. Ethical Considerations of Verbal Versus Written Consent for Minor Dermatologic Procedures. J Am[...]
Zimmerman MP, Huang AY, Cox EK, Al Abosy R, Chong WL, Bastian AG, Vietor K, Choutri YA, Collier JL, Zhabotynsky V, Wang H, Fung M,[...]